Android app Apple app link

Travere Therapeutics, Inc. (TVTX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$31.09

$0.9 (-2.81%)
Last update: 11:52 PM EST
Day's range
$30.69
Day's range
$31.96

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/14/2026 Guggenheim Vamil Divan $49.00 $28.39   72.58%
09/10/2025 Jefferies Maury Raycroft $35.00 $27.31   28.16%
10/31/2024 Evercore ISI Liisa Bayko $33.00 $17.50   88.57%
10/21/2024 Wells Fargo Mohit Bansal $27.00 $17.87   51.09%
10/10/2024 Evercore ISI Liisa Bayko $30.00 $18.07   66.02%
10/09/2024 Bank of America Securities Jason Zemansky $20.00 $15.21   31.49%
10/01/2024 Barclays Carter Gould $18.00 $13.99   28.66%
09/27/2024 Guggenheim Vamil Divan $23.00 $15.04   52.93%
09/27/2024 H.C. Wainwright Ed Arce $18.00 $15.04   19.68%
09/27/2024 Bank of America Securities Greg Harrison $18.00 $14.01   28.48%
09/10/2024 Canaccord Genuity Ed Nash $23.00 $12.70   81.17%
09/09/2024 Guggenheim Vamil Divan $25.00 $6.31   296.2%
08/28/2024 Piper Sandler Nicole Gabreski $12.00 $8.96   33.93%
08/02/2024 H.C. Wainwright Ed Arce $20.00 $4.62   332.9%
05/07/2024 Canaccord Genuity Ed Nash $18.00 $3.28   448.78%
04/24/2024 H.C. Wainwright Ed Arce $19.00 $2.74   593.43%

Travere Therapeutics, Inc. FAQ's

Travere Therapeutics, Inc. has been rated by research analysts at Guggenheim, Jefferies, Evercore ISI, Wells Fargo, Bank of America Securities, Barclays in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.